Report Detail

Pharma & Healthcare Global Drug-Device Combination Products Market Insights, Forecast to 2025

  • RnM2923655
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The growing prevalence of chronic diseases among elderly population, creates an inevitable need for effective therapeutic solutions. In light of such need, pharmaceutical and medical device industries now offer “Combination products”.
The global Drug-Device Combination Products market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drug-Device Combination Products market based on company, product type, end user and key regions.

This report studies the global market size of Drug-Device Combination Products in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug-Device Combination Products in these regions.
This research report categorizes the global Drug-Device Combination Products market by top players/brands, region, type and end user. This report also studies the global Drug-Device Combination Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott
Boston Scientific Corporation
Cook Medical
Medtronic
Smith & Nephew
St. Jude Medical
Stryker Corporation
Zimmer
Ethicon
C.R. Bard

Market size by Product
Drug Eluting Stents
Photosensitizers
Orthopaedic products
Infusion Pumps
Wound Care Products
Inhalers
Transdermal Patches 
Others
Market size by End User
Cardiovascular
Non-Cardiovascular
Urological
Bone Treatment
Antimicrobial treatment
Cancer Treatment
Ophthalmic Treatment 
Diabetes Treatment

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drug-Device Combination Products market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drug-Device Combination Products market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drug-Device Combination Products companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drug-Device Combination Products submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drug-Device Combination Products are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drug-Device Combination Products market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Drug-Device Combination Products Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Drug-Device Combination Products Market Size Growth Rate by Product
      • 1.4.2 Drug Eluting Stents
      • 1.4.3 Photosensitizers
      • 1.4.4 Orthopaedic products
      • 1.4.5 Infusion Pumps
      • 1.4.6 Wound Care Products
      • 1.4.7 Inhalers
      • 1.4.8 Transdermal Patches
      • 1.4.9 Others
    • 1.5 Market by End User
      • 1.5.1 Global Drug-Device Combination Products Market Size Growth Rate by End User
      • 1.5.2 Cardiovascular
      • 1.5.3 Non-Cardiovascular
      • 1.5.4 Urological
      • 1.5.5 Bone Treatment
      • 1.5.6 Antimicrobial treatment
      • 1.5.7 Cancer Treatment
      • 1.5.8 Ophthalmic Treatment
      • 1.5.9 Diabetes Treatment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Drug-Device Combination Products Market Size
      • 2.1.1 Global Drug-Device Combination Products Revenue 2014-2025
      • 2.1.2 Global Drug-Device Combination Products Sales 2014-2025
    • 2.2 Drug-Device Combination Products Growth Rate by Regions
      • 2.2.1 Global Drug-Device Combination Products Sales by Regions
      • 2.2.2 Global Drug-Device Combination Products Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Drug-Device Combination Products Sales by Manufacturers
      • 3.1.1 Drug-Device Combination Products Sales by Manufacturers
      • 3.1.2 Drug-Device Combination Products Sales Market Share by Manufacturers
      • 3.1.3 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drug-Device Combination Products Revenue by Manufacturers
      • 3.2.1 Drug-Device Combination Products Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug-Device Combination Products Revenue Share by Manufacturers (2014-2019)
    • 3.3 Drug-Device Combination Products Price by Manufacturers
    • 3.4 Drug-Device Combination Products Manufacturing Base Distribution, Product Types
      • 3.4.1 Drug-Device Combination Products Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Drug-Device Combination Products Product Type
      • 3.4.3 Date of International Manufacturers Enter into Drug-Device Combination Products Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Drug-Device Combination Products Sales by Product
    • 4.2 Global Drug-Device Combination Products Revenue by Product
    • 4.3 Drug-Device Combination Products Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Drug-Device Combination Products Breakdown Data by End User

    6 North America

    • 6.1 North America Drug-Device Combination Products by Countries
      • 6.1.1 North America Drug-Device Combination Products Sales by Countries
      • 6.1.2 North America Drug-Device Combination Products Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Drug-Device Combination Products by Product
    • 6.3 North America Drug-Device Combination Products by End User

    7 Europe

    • 7.1 Europe Drug-Device Combination Products by Countries
      • 7.1.1 Europe Drug-Device Combination Products Sales by Countries
      • 7.1.2 Europe Drug-Device Combination Products Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Drug-Device Combination Products by Product
    • 7.3 Europe Drug-Device Combination Products by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Drug-Device Combination Products by Countries
      • 8.1.1 Asia Pacific Drug-Device Combination Products Sales by Countries
      • 8.1.2 Asia Pacific Drug-Device Combination Products Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Drug-Device Combination Products by Product
    • 8.3 Asia Pacific Drug-Device Combination Products by End User

    9 Central & South America

    • 9.1 Central & South America Drug-Device Combination Products by Countries
      • 9.1.1 Central & South America Drug-Device Combination Products Sales by Countries
      • 9.1.2 Central & South America Drug-Device Combination Products Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Drug-Device Combination Products by Product
    • 9.3 Central & South America Drug-Device Combination Products by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Drug-Device Combination Products by Countries
      • 10.1.1 Middle East and Africa Drug-Device Combination Products Sales by Countries
      • 10.1.2 Middle East and Africa Drug-Device Combination Products Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Drug-Device Combination Products by Product
    • 10.3 Middle East and Africa Drug-Device Combination Products by End User

    11 Company Profiles

    • 11.1 Abbott
      • 11.1.1 Abbott Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Drug-Device Combination Products Products Offered
      • 11.1.5 Abbott Recent Development
    • 11.2 Boston Scientific Corporation
      • 11.2.1 Boston Scientific Corporation Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Boston Scientific Corporation Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Boston Scientific Corporation Drug-Device Combination Products Products Offered
      • 11.2.5 Boston Scientific Corporation Recent Development
    • 11.3 Cook Medical
      • 11.3.1 Cook Medical Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cook Medical Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cook Medical Drug-Device Combination Products Products Offered
      • 11.3.5 Cook Medical Recent Development
    • 11.4 Medtronic
      • 11.4.1 Medtronic Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Medtronic Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Medtronic Drug-Device Combination Products Products Offered
      • 11.4.5 Medtronic Recent Development
    • 11.5 Smith & Nephew
      • 11.5.1 Smith & Nephew Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Smith & Nephew Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Smith & Nephew Drug-Device Combination Products Products Offered
      • 11.5.5 Smith & Nephew Recent Development
    • 11.6 St. Jude Medical
      • 11.6.1 St. Jude Medical Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 St. Jude Medical Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 St. Jude Medical Drug-Device Combination Products Products Offered
      • 11.6.5 St. Jude Medical Recent Development
    • 11.7 Stryker Corporation
      • 11.7.1 Stryker Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Stryker Corporation Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Stryker Corporation Drug-Device Combination Products Products Offered
      • 11.7.5 Stryker Corporation Recent Development
    • 11.8 Zimmer
      • 11.8.1 Zimmer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Zimmer Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Zimmer Drug-Device Combination Products Products Offered
      • 11.8.5 Zimmer Recent Development
    • 11.9 Ethicon
      • 11.9.1 Ethicon Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Ethicon Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Ethicon Drug-Device Combination Products Products Offered
      • 11.9.5 Ethicon Recent Development
    • 11.10 C.R. Bard
      • 11.10.1 C.R. Bard Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 C.R. Bard Drug-Device Combination Products Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 C.R. Bard Drug-Device Combination Products Products Offered
      • 11.10.5 C.R. Bard Recent Development

    12 Future Forecast

    • 12.1 Drug-Device Combination Products Market Forecast by Regions
      • 12.1.1 Global Drug-Device Combination Products Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Drug-Device Combination Products Revenue Forecast by Regions 2019-2025
    • 12.2 Drug-Device Combination Products Market Forecast by Product
      • 12.2.1 Global Drug-Device Combination Products Sales Forecast by Product 2019-2025
      • 12.2.2 Global Drug-Device Combination Products Revenue Forecast by Product 2019-2025
    • 12.3 Drug-Device Combination Products Market Forecast by End User
    • 12.4 North America Drug-Device Combination Products Forecast
    • 12.5 Europe Drug-Device Combination Products Forecast
    • 12.6 Asia Pacific Drug-Device Combination Products Forecast
    • 12.7 Central & South America Drug-Device Combination Products Forecast
    • 12.8 Middle East and Africa Drug-Device Combination Products Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Drug-Device Combination Products Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Drug-Device Combination Products . Industry analysis & Market Report on Drug-Device Combination Products is a syndicated market report, published as Global Drug-Device Combination Products Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Drug-Device Combination Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,910.20
      5,865.30
      7,820.40
      4,576.60
      6,864.90
      9,153.20
      765,723.00
      1,148,584.50
      1,531,446.00
      409,101.00
      613,651.50
      818,202.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report